These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32192199)

  • 21. 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders.
    Benek O; Hroch L; Aitken L; Gunn-Moore F; Vinklarova L; Kuca K; Perez DI; Perez C; Martinez A; Fisar Z; Musilek K
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):665-670. PubMed ID: 29536773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of Type 10 17β-Hydroxysteroid Dehydrogenase in the Pathogenesis of Infantile Neurodegeneration and Alzheimer's Disease.
    He XY; Frackowiak J; Dobkin C; Brown WT; Yang SY
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evolutionary genomics of the HADH2 gene encoding Abeta-binding alcohol dehydrogenase/17beta-hydroxysteroid dehydrogenase type 10 (ABAD/HSD10).
    Marques AT; Antunes A; Fernandes PA; Ramos MJ
    BMC Genomics; 2006 Aug; 7():202. PubMed ID: 16899120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-3 Steroidal Hemiesters as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 10.
    Hanzlova M; Slavikova B; Morozovova M; Musilek K; Rotterova A; Zemanová L; Kudova E
    ACS Omega; 2024 Mar; 9(10):12116-12124. PubMed ID: 38496976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders.
    Yang SY; He XY; Isaacs C; Dobkin C; Miller D; Philipp M
    J Steroid Biochem Mol Biol; 2014 Sep; 143():460-72. PubMed ID: 25007702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease.
    Marques AT; Fernandes PA; Ramos MJ
    Mini Rev Med Chem; 2009 Jul; 9(8):1002-8. PubMed ID: 19601895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.
    Morsy A; Trippier PC
    J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
    Su X; Vicker N; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):214-7. PubMed ID: 16325333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme. Characterization of a novel 17beta-hydroxysteroid dehydrogenase.
    He XY; Merz G; Mehta P; Schulz H; Yang SY
    J Biol Chem; 1999 May; 274(21):15014-9. PubMed ID: 10329704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of 17β-Hydroxysteroid Dehydrogenase Type 10 and Cyclophilin D in Alzheimer's Disease.
    Kristofikova Z; Springer T; Gedeonova E; Hofmannova A; Ricny J; Hromadkova L; Vyhnalek M; Laczo J; Nikolai T; Hort J; Petrasek T; Stuchlik A; Vales K; Klaschka J; Homola J
    Neurochem Res; 2020 Apr; 45(4):915-927. PubMed ID: 31997103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease.
    Valasani KR; Hu G; Chaney MO; Yan SS
    Chem Biol Drug Des; 2013 Feb; 81(2):238-49. PubMed ID: 23039767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of 17β-Hydroxysteroid Dehydrogenase Type 10 in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Various Types of Dementias.
    Kristofikova Z; Ricny J; Vyhnalek M; Hort J; Laczo J; Sirova J; Klaschka J; Ripova D
    J Alzheimers Dis; 2015; 48(1):105-14. PubMed ID: 26401932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levels of 17β-hydroxysteroid dehydrogenase type 10 in CSF are not a valuable biomarker for multiple sclerosis.
    Kristofikova Z; Ricny J; Kaping D; Klaschka J; Kotoucova J; Bartos A
    Biomark Med; 2018 Dec; 12(12):1331-1340. PubMed ID: 30520659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of type 10 17beta-hydroxysteroid dehydrogenase in intracrinology and metabolism of isoleucine and fatty acids.
    He XY; Yang SY
    Endocr Metab Immune Disord Drug Targets; 2006 Mar; 6(1):95-102. PubMed ID: 16611167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities.
    Perspicace E; Cozzoli L; Gargano EM; Hanke N; Carotti A; Hartmann RW; Marchais-Oberwinkler S
    Eur J Med Chem; 2014 Aug; 83():317-37. PubMed ID: 24974351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD.
    Shafqat N; Marschall HU; Filling C; Nordling E; Wu XQ; Björk L; Thyberg J; Mårtensson E; Salim S; Jörnvall H; Oppermann U
    Biochem J; 2003 Nov; 376(Pt 1):49-60. PubMed ID: 12917011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New inhibitors of fungal 17beta-hydroxysteroid dehydrogenase based on the [1,5]-benzodiazepine scaffold.
    Zivec M; Sova M; Brunskole M; Lenarsic R; Rizner TL; Gobec S
    J Enzyme Inhib Med Chem; 2007 Feb; 22(1):29-36. PubMed ID: 17373544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase.
    He XY; Yang YZ; Peehl DM; Lauderdale A; Schulz H; Yang SY
    J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):191-8. PubMed ID: 14672739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics.
    Vangavaragu JR; Valasani KR; Fang D; Williams TD; Yan SS
    J Alzheimers Dis; 2014; 42(1):333-44. PubMed ID: 24858403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.
    Valaasani KR; Sun Q; Hu G; Li J; Du F; Guo Y; Carlson EA; Gan X; Yan SS
    Curr Alzheimer Res; 2014 Feb; 11(2):128-36. PubMed ID: 24479630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.